Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2013 1
2015 2
2016 1
2017 1
2018 5
2019 4
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study.
Bisecco A, Fornasiero A, Bianco A, Cortese A, D'Amico E, Mataluni G, Sinisi L, Spitaleri D, Docimo R, Buscarinu MC, Mirabella M, Crisafulli SG, Zanghì A, Nicoletti CG, Salvetti M, Baione V, Patti F, Marfia AG, Sibilia G, Scarano V, Orlando D, Stabile G, Tedeschi G, Gallo A. Bisecco A, et al. Among authors: fornasiero a. J Neurol. 2022 May;269(5):2824-2825. doi: 10.1007/s00415-022-11083-1. J Neurol. 2022. PMID: 35344079 Free PMC article. No abstract available.
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Dimethylfumarate.
Buscarinu MC, Gargano F, Lionetto L, Capi M, Morena E, Fornasiero A, Reniè R, Landi AC, Pellicciari G, Romano C, Mechelli R, Romano S, Borsellino G, Battistini L, Simmaco M, Fagnani C, Salvetti M, Ristori G. Buscarinu MC, et al. Among authors: fornasiero a. Front Neurol. 2021 Aug 26;12:683398. doi: 10.3389/fneur.2021.683398. eCollection 2021. Front Neurol. 2021. PMID: 34512507 Free PMC article.
Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study.
Alvino B, Arianna F, Assunta B, Antonio C, Emanuele D, Giorgia M, Leonardo S, Daniele S, Renato D, Buscarinu MC, Massimiliano M, Crisafulli SG, Aurora Z, Gabri Nicoletti C, Marco S, Viola B, Francesco P, Marfia AG, Grazia S, Valentina S, Davide O, Giovanni S, Gioacchino T, Gallo A. Alvino B, et al. Among authors: arianna f. J Neurol. 2022 Mar;269(3):1610-1617. doi: 10.1007/s00415-021-10737-w. Epub 2021 Aug 4. J Neurol. 2022. PMID: 34347149 Free PMC article.
The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology.
Buscarinu MC, Fornasiero A, Romano S, Ferraldeschi M, Mechelli R, Reniè R, Morena E, Romano C, Pellicciari G, Landi AC, Salvetti M, Ristori G. Buscarinu MC, et al. Among authors: fornasiero a. Front Immunol. 2019 Aug 28;10:1916. doi: 10.3389/fimmu.2019.01916. eCollection 2019. Front Immunol. 2019. PMID: 31555257 Free PMC article. Review.
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.
Romano S, Ferraldeschi M, Bagnato F, Mechelli R, Morena E, Caldano M, Buscarinu MC, Fornasiero A, Frontoni M, Nociti V, Mirabella M, Mayer F, Bertolotto A, Pozzilli C, Vanacore N, Salvetti M, Ristori G. Romano S, et al. Among authors: fornasiero a. Front Neurol. 2019 Jul 16;10:695. doi: 10.3389/fneur.2019.00695. eCollection 2019. Front Neurol. 2019. PMID: 31379701 Free PMC article.
Genome-Wide Multiple Sclerosis Association Data and Coagulation.
La Starza S, Ferraldeschi M, Buscarinu MC, Romano S, Fornasiero A, Mechelli R, Umeton R, Ristori G, Salvetti M. La Starza S, et al. Among authors: fornasiero a. Front Neurol. 2019 Feb 14;10:95. doi: 10.3389/fneur.2019.00095. eCollection 2019. Front Neurol. 2019. PMID: 30837932 Free PMC article. Review.
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients.
Annibali V, Umeton R, Palermo A, Severa M, Etna MP, Giglio S, Romano S, Ferraldeschi M, Buscarinu MC, Vecchione A, Annese A, Policano C, Mechelli R, Pizzolato Umeton R, Fornasiero A, Angelini DF, Guerrera G, Battistini L, Coccia EM, Salvetti M, Ristori G. Annibali V, et al. Among authors: fornasiero a. J Neuroimmunol. 2018 Nov 15;324:165-171. doi: 10.1016/j.jneuroim.2018.09.005. Epub 2018 Sep 15. J Neuroimmunol. 2018. PMID: 30270021
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.
Prosperini L, Annovazzi P, Boffa L, Buscarinu MC, Gallo A, Matta M, Moiola L, Musu L, Perini P, Avolio C, Barcella V, Bianco A, Farina D, Ferraro E, Pontecorvo S, Granella F, Grimaldi LME, Laroni A, Lus G, Patti F, Pucci E, Pasca M, Sarchielli P; Italian Alemtuzumab Study Group. Prosperini L, et al. J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26. J Neurol. 2018. PMID: 30259178
Corrigendum to "Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia" [Clin. Neurol. Neurosurg. 168 (May) (2018) 60-63].
Coarelli G, Romano S, Travaglini L, Ferraldeschi M, Nicita F, Spadaro M, Fornasiero A, Frontali M, Salvetti M, Bertini E, Ristori G. Coarelli G, et al. Among authors: fornasiero a. Clin Neurol Neurosurg. 2018 Sep;172:190. doi: 10.1016/j.clineuro.2018.06.025. Epub 2018 Jun 30. Clin Neurol Neurosurg. 2018. PMID: 29970275 No abstract available.
17 results